Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 16–30 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-6235 ABCC8 Gene Transient Neonatal Diabetes Mellitus Type 2 Genetic Test This test identifies pathogenic variants in the ABCC8 gene associated with transient neonatal diabetes mellitus type 2.	Whole Blood (EDTA) or Dried Blood Spot	3–4 Weeks (expedited available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ABCC8 gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Diagnosis of transient neonatal diabetes mellitus type 2", "Differentiation from permanent neonatal diabetes"] Measurement technique Confirm with laboratory Codes LOINC: 82237-3 ICD-10: P70.2 Clinical summary This test identifies pathogenic variants in the ABCC8 gene associated with transient neonatal diabetes mellitus type 2.
TEST-5465 Abnormal Mineralization Panel (Genetic Test) This test identifies pathogenic variants in 58 genes associated with complex skeletal, dermatological, and immunological mineralization disorders.	Whole Blood (EDTA)	3 to 4 Weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in 58 genes", "Single nucleotide variants (SNVs)", "Insertions/Deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation [] Indications ["Patients presenting with a perplexing mix of symptoms suggestive of mineralization disorders.", "Cases where standard diagnostic pathways are inconclusive.", "Need for a definitive etiological diagnosis to guide personalized therapy."] Measurement technique Confirm with laboratory Codes LOINC: 101363-0 ICD-10: E83.39 Clinical summary This test identifies pathogenic variants in 58 genes associated with complex skeletal, dermatological, and immunological mineralization disorders.
TEST-1875 Achondroplasia Mutation Analysis (FGFR3 Gene G1138A, G1138C) Test This test identifies the most common genetic mutations (G1138A and G1138C) in the FGFR3 gene associated with achondroplasia.	Peripheral Whole Blood (3–5 mL EDTA)	10–12 Working Days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FGFR3 gene mutations (c.1138G>A, c.1138G>C)", "Presence of specific pathogenic variants"] Parameters [] Preparation ["No fasting required"] Indications ["Clinical suspicion of achondroplasia", "Prenatal screening for achondroplasia", "Family history of achondroplasia", "Genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 91761-6 ICD-10: Q77.4 Clinical summary This test identifies the most common genetic mutations (G1138A and G1138C) in the FGFR3 gene associated with achondroplasia.
TEST-4272 ACTC1 Gene Test This test identifies pathogenic variants in the ACTC1 gene, which are associated with Familial Hypertrophic Cardiomyopathy Type 11.	Peripheral whole blood (4 mL EDTA tube)	3–4 Weeks (21–28 calendar days from sample receipt)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACTC1 gene", "Coding regions and splice junctions of ACTC1"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory"] Indications ["Diagnosis of Familial Hypertrophic Cardiomyopathy Type 11", "Cascade screening for at-risk family members", "Pre-conception risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 92934-7 ICD-10: I42.1, Z13.71 Clinical summary This test identifies pathogenic variants in the ACTC1 gene, which are associated with Familial Hypertrophic Cardiomyopathy Type 11.
TEST-4349 ACTN2 Gene Dilated Cardiomyopathy Type 1AA Genetic Test This genetic test evaluates the ACTN2 gene for pathogenic variants linked to dilated cardiomyopathy type 1AA.	Peripheral whole blood (EDTA tube)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACTN2 gene", "Single nucleotide variants", "Small insertions and deletions", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Individuals with a family history of cardiomyopathy", "Individuals with unexplained heart failure", "Familial risk stratification"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: I42.0 Clinical summary This genetic test evaluates the ACTN2 gene for pathogenic variants linked to dilated cardiomyopathy type 1AA.
TEST-101 ACTN3 (Sports Gene) Genotyping Test This test identifies the R577X polymorphism in the ACTN3 gene, indicating genetic predisposition towards power or endurance sports.	4 mL whole blood (EDTA)	10 working days	950.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACTN3 gene R577X polymorphism", "Alpha-actinin-3 protein presence"] Parameters [] Preparation [] Indications ["Athletic performance optimization", "Personalized training guidance", "Genetic predisposition assessment"] Measurement technique Confirm with laboratory Codes LOINC: 25233-7 ICD-10: Z13.8 Clinical summary This test identifies the R577X polymorphism in the ACTN3 gene, indicating genetic predisposition towards power or endurance sports.
TEST-3869 ACTN4 Gene (FSGS Type 1) Next-Generation Sequencing Genetic Test This genetic test evaluates the ACTN4 gene for pathogenic variants associated with autosomal dominant FSGS Type 1.	Whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACTN4 gene", "Coverage of entire coding region and splice sites"] Parameters [] Preparation [] Indications ["Diagnosis of suspected FSGS Type 1", "Genetic risk assessment for family members of FSGS Type 1 patients"] Measurement technique Confirm with laboratory Codes LOINC: 21613-5 ICD-10: N04.1, Z15.09 Clinical summary This genetic test evaluates the ACTN4 gene for pathogenic variants associated with autosomal dominant FSGS Type 1.
TEST-126 Adenovirus Qualitative PCR Test This test detects the presence or absence of adenovirus DNA in whole blood or CSF.	Whole Blood (EDTA) or Cerebrospinal Fluid (CSF)	2–3 working days	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Adenovirus DNA presence"] Parameters [] Preparation ["No fasting required", "Maintain hydration", "Notify of blood-thinning medications"] Indications ["Suspected adenovirus infection", "Diagnosis in immunocompromised patients", "Severe respiratory or neurological presentations", "Infection control measures"] Measurement technique Confirm with laboratory Codes LOINC: 20416-4 ICD-10: B34.0 Clinical summary This test detects the presence or absence of adenovirus DNA in whole blood or CSF.
TEST-186 Advanced Diploid/Polyploid Genomic Architecture Analysis (Illumina) Test This test evaluates genomic architecture, focusing on ploidy determination and complex structural variants using Illumina sequencing.	Whole Blood	28 Days	12,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genomic Architecture", "Ploidy Determination", "Complex Structural Variants", "Allele Frequency"] Parameters [{"name": "Precision (Ploidy Caller)", "reference_range": "Allele Frequency-based Bayesian Model (Polyploid-aware)"}] Preparation ["Do not discontinue prescribed medications, including anticoagulants or immunosuppressants, without explicit instruction from your referring physician."] Indications ["Suspected polyploidy syndromes", "Validation of variant calling in polyploid organisms", "Translational biobank research"] Measurement technique Confirm with laboratory Codes LOINC: 81255-3 ICD-10: Q92.8, R89.1 Clinical summary This test evaluates genomic architecture, focusing on ploidy determination and complex structural variants using Illumina sequencing.
TEST-184 Advanced Human Genome Reference-Based Analysis (Illumina) Test This test analyzes the entire genome using Next-Generation Sequencing (Illumina) to identify pathogenic variants associated with over 1,000 inherited conditions and disease suscept...	Whole Blood (Peripheral)	4 Weeks	6,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants", "Disease susceptibility variants", "Carrier status"] Parameters [] Preparation [] Indications ["Assessment of risk for inherited conditions", "Identification of disease susceptibilities", "Carrier status screening"] Measurement technique Confirm with laboratory Codes LOINC: 60524-1 ICD-10: Z13.89 Clinical summary This test analyzes the entire genome using Next-Generation Sequencing (Illumina) to identify pathogenic variants associated with over 1,000 inherited conditions and disease susceptibilities.
TEST-5073 AFF2 Gene (FRAXE Fragile Site) Mental Retardation, X-Linked NGS Test This test evaluates the AFF2 gene for pathogenic variants associated with X-linked mental retardation (FRAXE syndrome). It utilizes Next-Generation Sequencing (NGS) with CNV and me...	Peripheral whole blood (5 mL in PAXgene tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AFF2 gene sequence variants (point mutations, deletions)", "AFF2 gene copy number variations (CNV)", "FRAXE locus methylation status"] Parameters [] Preparation ["Fast for at least 4 hours before the blood draw (water permitted).", "Mandatory pre-test genetic counselling session required."] Indications ["Diagnosis of FRAXE intellectual disability", "Carrier screening for at-risk relatives", "Evaluation of developmental delay of unknown origin"] Measurement technique Confirm with laboratory Codes LOINC: 81326-5 ICD-10: Q99.8, F78 Clinical summary This test evaluates the AFF2 gene for pathogenic variants associated with X-linked mental retardation (FRAXE syndrome). It utilizes Next-Generation Sequencing (NGS) with CNV and methylation analysis.
TEST-5883 AFG3L2 Gene Spinocerebellar Ataxia Type 28, Autosomal Dominant Genetic Test This genetic test identifies pathogenic variants in the AFG3L2 gene associated with autosomal dominant spinocerebellar ataxia type 28.	Peripheral whole blood (EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AFG3L2 gene", "Exonic variants", "Splice-site variants", "Copy-number variants"] Parameters [] Preparation ["No fasting required", "Provide comprehensive clinical and family neurological history"] Indications ["Diagnosis of suspected SCA28", "Family risk assessment for SCA28", "Genetic counselling for hereditary ataxia"] Measurement technique Confirm with laboratory Codes LOINC: 94475-6 ICD-10: G11.8 Clinical summary This genetic test identifies pathogenic variants in the AFG3L2 gene associated with autosomal dominant spinocerebellar ataxia type 28.
TEST-4121 AGK Gene Genetic Test for Sengers Syndrome This test evaluates the AGK gene for pathogenic variants associated with Sengers syndrome.	Peripheral whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single-nucleotide variants in AGK gene", "Small insertions/deletions in AGK gene", "Copy-number variations in AGK gene"] Parameters [] Preparation ["Genetic counselling session required prior to sample collection", "Inform phlebotomist if on anticoagulant therapy"] Indications ["Clinical suspicion of Sengers syndrome", "Family history of Sengers syndrome", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 21641-0 ICD-10: E88.4, E88.49 Clinical summary This test evaluates the AGK gene for pathogenic variants associated with Sengers syndrome.
TEST-5199 AGRN Gene Congenital Myasthenic Syndrome (CMS) Genetic Test This genetic test evaluates the AGRN gene for pathogenic variants associated with congenital myasthenic syndrome.	Peripheral whole blood (EDTA)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AGRN gene", "Coding region and splice junctions of AGRN"] Parameters [] Preparation ["No fasting required", "Do not stop prescribed medication without doctor's approval"] Indications ["Suspected congenital myasthenic syndrome", "Family history of CMS"] Measurement technique Confirm with laboratory Codes LOINC: 101502-6 ICD-10: G70.2, Z15.89, Z13.71 Clinical summary This genetic test evaluates the AGRN gene for pathogenic variants associated with congenital myasthenic syndrome.
TEST-1926 AIP Gene Germline Mutation Analysis (NGS) Test This test evaluates the AIP gene for germline mutations associated with pituitary adenomas.	Whole Blood (Peripheral Blood, EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the AIP gene", "Single-nucleotide variants", "Small insertions/deletions", "Large copy-number alterations"] Parameters [] Preparation ["Patients should not alter or discontinue therapy without consulting their endocrinologist."] Indications ["Suspected familial isolated pituitary adenoma (FIPA)", "Endocrine surgical planning", "Familial cascade screening", "Long-term surveillance protocols"] Measurement technique Confirm with laboratory Codes LOINC: 83349-5 ICD-10: D35.2, Z15.09 Clinical summary This test evaluates the AIP gene for germline mutations associated with pituitary adenomas.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories